CTCBIO Inc. (KOSDAQ:060590)

South Korea · Delayed Price · Currency is KRW

3,705.00

-190.00 (-4.88%)

At close: Apr 2, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Consolidation Adjustments			-5.25B	-8.60B	-3.74B	-1.62B	-7.96B
Animal and Human Medicine Sale			116.35B	139.44B	114.19B	103.29B	108.30B
Animal and Human Medicine Sale Growth			-16.56%	22.12%	10.55%	-4.62%	5.83%
Hay Sale			24.93B	32.90B	29.67B	28.36B	31.25B
Hay Sale Growth			-24.22%	10.90%	4.63%	-9.24%	-13.46%
Health Functional Food Sales			1.85B	1.45B	199.89M	-	4.53B
Health Functional Food Sales Growth			27.20%	626.67%	-	-	66.25%
Total			137.88B	165.21B	140.32B	130.03B	136.12B
Total Growth			-16.54%	17.74%	7.91%	-4.48%	-1.36%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea			141.28B	172.35B	143.86B	131.65B	139.55B
South Korea Growth			-18.02%	19.80%	9.27%	-5.66%	1.40%
Overseas			1.85B	1.45B	199.89M	-	4.53B
Overseas Growth			27.20%	626.67%	-	-	27.73%
Consolidated Adjustments			-5.25B	-8.60B	-3.74B	-1.62B	-7.96B
Total			137.88B	165.21B	140.32B	130.03B	136.12B
Total Growth			-16.54%	17.74%	7.91%	-4.48%	-1.36%

Source: S&P Global Market Intelligence.